About UsServicesExpertiseWorking GroupsNewsStudies

Genetic Testing for Prostate Cancer: Considerations for Practice Virtual Genetics Board

pcctcadmin | January 12, 2022

  • Recent Posts

    • The PCCTC’s IRONMAN Registry Receives PCF Challenge Award
    • The PCCTC at ASCO22
    • Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling
    • Genetic Testing for Prostate Cancer: Considerations for Practice Virtual Genetics Board
    • The transformative development and progress of the The PCCTC via UroToday

  • Recent Comments

    • Archives

      • January 2023
      • June 2022
      • January 2022
      • June 2020
      • August 2019

    • Categories

      • Media Relations
      • Press Releases
      • Uncategorized

    • Meta

      • Log in
      • Entries feed
      • Comments feed
      • WordPress.org

    Designing, implementing, and completing hypothesis-driven early phase trials in prostate cancer.

    Stay Connected

    About

    • Our Mission
    • Our History
    • Our Leadership
    • Our Participants

    Contact

    Working Groups

    Services

    • Project Management
    • Advisory Board
    • Contracts & Budgets
    • Regulatory
    • Medical Writing
    • Clinical Data Management
    • Statistical Analysis
    • Correlative Science & Laboratorial Services

    Expertise

    • Our Investigators
    • Drug Development
    • Biomarker Development

    Studies

    • DORA
    • Ironman

    News

    • Press Releases
    • Media Relations
    © 2023 The Prostate Cancer Clinical Trials Consortium. All Rights Reserved.